Qube Research & Technologies LTD Novartis Ag Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Novartis Ag stock. As of the latest transaction made, Qube Research & Technologies LTD holds 400 shares of NVS stock, worth $52,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares

400

Previous 39,723 98.99%

Holding current value

$52,308

Previous $4.43 Million 98.92%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$97.14 - $115.57 $57.8 Million - $68.7 Million	-594,851 Reduced 93.74%	39,723 $4.43 Million
Q4 2024 Feb 14, 2025	BUY	$96.78 - $117.18 $46.1 Million - $55.8 Million	476,420 Added 301.24%	634,574 $61.8 Million
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $1.84 Million - $2.09 Million	-17,329 Reduced 9.88%	158,154 $18.2 Million
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $51.3 Million - $59.5 Million	-554,229 Reduced 75.95%	175,483 $18.7 Million
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $36.7 Million - $41.8 Million	385,402 Added 111.93%	729,712 $70.6 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $20.9 Million - $23 Million	226,515 Added 192.3%	344,310 $34.8 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $8.34 Million - $9.25 Million	-87,989 Reduced 42.76%	117,795 $12 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $19 Million - $21.6 Million	205,784 New	205,784 $20.8 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $3.76 Million - $4.6 Million	49,736 Added 43.1%	165,124 $15 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $5.23 Million - $6.12 Million	-70,151 Reduced 37.81%	115,388 $8.77 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $11.4 Million - $13.2 Million	141,326 Added 319.65%	185,539 $15.7 Million
Q1 2022 May 09, 2022	BUY	$80.11 - $90.62 $3.54 Million - $4.01 Million	44,213 New	44,213 $3.88 Million
Q4 2021 Feb 01, 2022	SELL	$79.7 - $88.13 $8.22 Million - $9.09 Million	-103,144 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $88,322 - $102,751	-1,080 Reduced 1.04%	103,144 $8.44 Million
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $8.65 Million - $9.56 Million	101,518 Added 3751.59%	104,224 $9.51 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $225,951 - $266,459	2,706 New	2,706 $231,000
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $5.4 Million - $6.53 Million	-69,165 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $4.26 Million - $4.72 Million	51,907 Added 300.77%	69,165 $6.02 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $1.4 Million - $1.57 Million	17,258 New	17,258 $1.51 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $1.05 Million - $1.47 Million	-14,829 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $1.25 Million - $1.41 Million	14,829 New	14,829 $1.4 Million

Others Institutions Holding NVS

# of Institutions

1,561

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $281B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Novartis Ag Transaction History